Cargando…

Dyslipidemia in adolescents and young adults with type 1 and type 2 diabetes: a retrospective analysis

BACKGROUND: Youth onset type 1 diabetes (T1D) and type 2 diabetes (T2D) is increasing and associated with earlier vascular complications and mortality. Dyslipidemia is an important modifiable cardiovascular (CVD) risk factor that is under-recognized and undertreated in youth with T1D and T2D. Given...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Grace, DeSalvo, Daniel, Guffey, Danielle, Minard, Charles G., Cephus, Constance, Moodie, Douglas, Lyons, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288506/ https://www.ncbi.nlm.nih.gov/pubmed/32536946 http://dx.doi.org/10.1186/s13633-020-00081-7

Ejemplares similares

Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study
por: Sheikh, Khalid, et al.
Publicado: (2018)

Treatment of dyslipidemia in patients with type 2 diabetes
por: Vijayaraghavan, Krishnaswami
Publicado: (2010)

Dyslipidemia in Pediatric Type 2 Diabetes Mellitus
por: Sunil, Bhuvana, et al.
Publicado: (2020)

Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes
por: Prahalad, Priya, et al.
Publicado: (2021)

Improvements in Glycemic Outcomes in 4738 Children, Adolescents, and Adults with Type 1 Diabetes Initiating a Tubeless Insulin Management System
por: Aleppo, Grazia, et al.
Publicado: (2023)

Serum Cystatin C as a Biomarker for Early Diabetic Kidney Disease and Dyslipidemia in Young Type 1 Diabetes Patients
por: Stankute, Ingrida, et al.
Publicado: (2022)

Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes
por: Pokharel, Daya Ram, et al.
Publicado: (2017)

Revisiting cardiovascular risk reduction in type 2 diabetes and dyslipidemia
por: Lim, Phillip, et al.
Publicado: (2022)

The Problem of Abnormal Body Weight and Dyslipidemia as Risk Factors for Cardiovascular Diseases in Children and Adolescents with Type 1 Diabetes
por: Noras, Katarzyna, et al.
Publicado: (2021)

Combination Steroid and Test-based Food Elimination for Eosinophilic Esophagitis: A Retrospective Analysis
por: Constantine, Gregory, et al.
Publicado: (2017)

Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia
por: Zaman Huri, Hasniza, et al.
Publicado: (2013)

Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment
por: Sugiyama, Kazutoshi, et al.
Publicado: (2018)

Therapies for the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes and Dyslipidemia
por: Aguilar-Ballester, María, et al.
Publicado: (2021)

HM-Chromanone Ameliorates Hyperglycemia and Dyslipidemia in Type 2 Diabetic Mice
por: Park, Jae Eun, et al.
Publicado: (2022)

Causes for Withdrawal in an Urban Peritoneal Dialysis Program
por: Workeneh, Biruh, et al.
Publicado: (2015)

Day-and-Night Closed-Loop Control Using the Unified Safety System in Adolescents With Type 1 Diabetes at Camp
por: Ly, Trang T., et al.
Publicado: (2016)

Hypoglycemia risk with physical activity in type 1 diabetes: a data-driven approach
por: Prasanna, Sahana, et al.
Publicado: (2023)

The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
por: Chatziralli, Irini P.
Publicado: (2017)

Pediatric continuous renal replacement therapy: have practice changes changed outcomes? A large single-center ten-year retrospective evaluation
por: Riley, Alyssa A., et al.
Publicado: (2018)

Diabetes Dyslipidemia
por: Schofield, Jonathan D., et al.
Publicado: (2016)

Genetic Predisposition to Dyslipidemia and Type 2 Diabetes Risk in Two Prospective Cohorts
por: Qi, Qibin, et al.
Publicado: (2012)

Clinical and Demographic Factors Associated With Diabetic Retinopathy Among Young Patients With Diabetes
por: Ferm, Michael L., et al.
Publicado: (2021)

Effect of Lipohypertrophy on Accuracy of Continuous Glucose Monitoring in Patients With Type 1 Diabetes
por: DeSalvo, Daniel J., et al.
Publicado: (2015)

Predictors of Dyslipidemia Over Time in Youth With Type 1 Diabetes: For the SEARCH for Diabetes in Youth Study
por: Shah, Amy S., et al.
Publicado: (2017)

Severe dyslipidemia associated with diabetic ketoacidosis in newly diagnosed female of type 1 diabetes mellitus
por: Chreitah, Ahmad, et al.
Publicado: (2021)

Isolation and Education During a Pandemic: Novel Telehealth Approach to Family Education for a Child With New-Onset Type 1 Diabetes and Concomitant COVID-19
por: Shawar, Reem S., et al.
Publicado: (2021)

Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
por: Tenenbaum, Alexander, et al.
Publicado: (2006)

Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment
por: Halpern, Alfredo, et al.
Publicado: (2010)

The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo
por: Kwai, Natalie C. G., et al.
Publicado: (2016)

HbA1c – A predictor of dyslipidemia in type 2 Diabetes Mellitus
por: Kidwai, Saera Suhail, et al.
Publicado: (2020)

Association of fetuin-A with dyslipidemia and insulin resistance in type-II Diabetics of Pakistani population
por: Fatima, Fasiha, et al.
Publicado: (2020)

New perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease
por: Matsuzaka, Takashi, et al.
Publicado: (2020)

Prevalence and pattern of dyslipidemia in patients with type 2 diabetes mellitus in Zaria, Northwestern Nigeria
por: Bello-Ovosi, Beatrice Ohunene, et al.
Publicado: (2019)

Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Al Ghadeer, Hussain A, et al.
Publicado: (2021)

Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors
por: Hyassat, Dana, et al.
Publicado: (2022)

Impact of using creative arts programming to support HIV treatment in adolescents and young adults in Eswatini
por: Ness, Tara E., et al.
Publicado: (2021)

Association of Dyslipidemia with Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients: A Hospital-Based Study
por: Ezhilvendhan, Kalaimamani, et al.
Publicado: (2021)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

Prevalence and types of persistent dyslipidemia in patients treated with statins
por: Reiner, Željko, et al.
Publicado: (2013)

Anthropometric and metabolic indices in assessment of type and severity of dyslipidemia
por: Zaid, Muhammad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6q0v7rdvt8k22nfri2paijvl6a